Trials / Recruiting
RecruitingNCT07255040
A Clinical Study to Evaluate the Effectiveness of an Experimental Toothpaste in Improving Gum Health and Reducing Plaque Accumulation
A 24-Week, Randomised, Controlled, Examiner-blind, Clinical Study to Evaluate the Efficacy of an Experimental Stannous Fluoride Dentifrice in Improving Gingival Health and Reducing Plaque Accumulation
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- HALEON · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of this 24-week clinical study is to evaluate the ability of an experimental dentifrice containing 0.454 percent (%) weight by weight (w/w) Stannous fluoride (SnF2); to improve gingival health, plaque reduction and prevention of plaque accumulation compared with a regular fluoride dentifrice (negative control) in participants with mild to moderate gingivitis.
Detailed description
This will be a single-center, 24-week, randomized, controlled, single blind (examiner only), 3-treatment arms, parallel group, stratified study, to evaluate the efficacy of using an experimental dentifrice containing 0.454% w/w Stannous fluoride, twice daily in reducing gingivitis and plaque accumulation in a population with clinically measurable level of gingivitis. The clinical efficacy of the experimental dentifrice will be compared to a commercially available regular fluoride dentifrice as negative control. In addition, a marketed dentifrice containing 0.454% w/w SnF2 is included as positive control to provide a well-established benchmark. Approximately 300 participants (approximately 100 per group) will be randomized to ensure approximately 270 evaluable participants (approximately 90 per group) complete the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Test Dentifrice | Experimental dentifrice containing 0.454% w/w SnF2. |
| DRUG | Parodontax Complete Protection | Marketed dentifrice containing 0.454% w/w SnF2. |
| DRUG | Colgate Cavity Protection | Marketed regular fluoride dentifrice. |
Timeline
- Start date
- 2025-11-19
- Primary completion
- 2026-07-01
- Completion
- 2026-07-01
- First posted
- 2025-11-28
- Last updated
- 2025-12-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07255040. Inclusion in this directory is not an endorsement.